Javid Moslehi

Javid Moslehi is a Professor of Medicine and Cardiology at the University of California San Francisco (UCSF), where he holds the William Grossman Distinguished Professorship in Cardiology. His research focuses on cardio-oncology and cardio-immunology, investigating cardiovascular complications of cancer therapies, particularly immune checkpoint inhibitors (ICIs). He leads multiple NIH-funded projects exploring mechanisms of ICI-associated myocarditis and other immune-related cardiovascular toxicities.

Education:

• Bachelor of Arts in Biology, Johns Hopkins University (1996)
• Doctor of Medicine, University of Connecticut School of Medicine (2001)

Research Interests:

• Mechanisms of immune-mediated cardiovascular injury
• Development of diagnostic biomarkers and therapies for ICI-induced myocarditis
• Interaction between the immune system and cardiovascular health
• Cardiac complications of targeted cancer therapies

Key Achievements:

• Discovered the first cases of fulminant myocarditis linked to ICI therapies (NEJM, 2016)
• Developed mouse models to study ICI-associated cardiovascular toxicities
• Recipient of the American Society of Clinical Investigation (ASCI) membership (2020)

Grants & Awards:

• NIH R01HL156021 (2021–2026): Immunologic Drivers of ICI-Myocarditis
• NIH R01HL155990 (2021–2026): Long-Term Cardiovascular Sequelae of Cancer Immunotherapies
• 2021 William Grossman Distinguished Professorship in Cardiology

Lab/Team: His laboratory integrates clinical research with translational studies, focusing on immune-cardiovascular interactions and therapeutic innovation.